Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.

ABSTRACT:

SUBMITTER: Eckhardt CM 

PROVIDER: S-EPMC7276974 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature